Veale D, Pépin J L, Wuyam B, Lévy P A
Dept of Respiratory Medicine, CHU Grenoble, France.
Eur Respir J. 1996 Oct;9(10):2122-6. doi: 10.1183/09031936.96.09102122.
Obstructive sleep apnoea (OSA) is associated with abnormalities in autonomic stress tests, which are tests of cardiovascular response in the autonomic nervous system (ANS). The level of abnormality has been related to the level of overnight arterial oxygen saturation (Sa,O2). We have studied ANS function pre- and post-treatment with nasal continuous positive airway pressure (nCPAP) in six males with moderately severe or severe OSA (apnoea/hypopnoea index (AHI) median 51 (range 14-74 events.h-1 of sleep). Tests consisted of heart rate responses to Valsalva manoeuvre, deep breathing, and change of posture from lying to standing. In addition, systolic blood pressure (SBP) response to standing and diastolic blood pressure (DBP) response to handgrip were studied. Each abnormal test (compared to published normal values) scored +1.0 and each marginal test result (90-95% confidence interval for normals) scored +0.5. A total score was calculated for the five tests performed in the evening and morning (maximum score 10 per patient). Patients had been receiving treatment for more than 1 year (median 471 (389-624) days) and objective compliance was monitored by a clock counter in the nCPAP machines. Five of six patients had regularly used nCPAP (mean 7.8 h.night-1) and all showed a normalization in ANS test score: pre-nCPAP 2 (1-4.5), post-nCPAP 0.2 (0-0.5) (p < 0.05, Wilcoxon signed rank test). One poorly compliant subject (No. 6; nCPAP 3 h.night-1) had a deterioration in ANS test score: 1 pre-nCPAP to 1.5 post-nCPAP. The improvement in ANS test score in the five compliant patients was positively correlated with an improvement in mean Sa,O2 during sleep posttreatment. We conclude that successful treatment of obstructive sleep apnoea leads to normalization of impaired autonomic stress responses.
阻塞性睡眠呼吸暂停(OSA)与自主神经应激试验异常有关,自主神经应激试验是对自主神经系统(ANS)心血管反应的测试。异常程度与夜间动脉血氧饱和度(Sa,O2)水平相关。我们研究了6名中度至重度OSA男性患者(呼吸暂停/低通气指数(AHI)中位数为51(范围为14 - 74次/小时睡眠事件))在接受鼻腔持续气道正压通气(nCPAP)治疗前后的ANS功能。测试包括对瓦尔萨尔瓦动作、深呼吸以及从卧位到站立位姿势改变的心率反应。此外,还研究了站立时的收缩压(SBP)反应和握力时的舒张压(DBP)反应。每项异常测试(与已发表的正常值相比)得 +1.0分,每项临界测试结果(正常范围的90 - 95%置信区间)得 +0.5分。计算晚上和早上进行的五项测试的总分(每位患者最高分为10分)。患者接受治疗超过1年(中位数为471(389 - 624)天),通过nCPAP机器中的时钟计数器监测客观依从性。6名患者中有5名经常使用nCPAP(平均每晚7.8小时),且所有患者的ANS测试得分均恢复正常:nCPAP治疗前为2(1 - 4.5),nCPAP治疗后为0.2(0 - 0.5)(p < 0.05,Wilcoxon符号秩检验)。一名依从性差的受试者(6号;每晚使用nCPAP 3小时)的ANS测试得分恶化:nCPAP治疗前为1分,nCPAP治疗后为1.5分。5名依从性好的患者的ANS测试得分改善与治疗后睡眠期间平均Sa,O2的改善呈正相关。我们得出结论,阻塞性睡眠呼吸暂停的成功治疗可使受损的自主神经应激反应恢复正常。